Tumor Landscape Pathological Diagnosis by Large Tissue Sections
NCT ID: NCT03376815
Last Updated: 2017-12-19
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
2000 participants
OBSERVATIONAL
2018-01-01
2021-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
prostate ,traditional sample method
Samples from 100 patients with prostate carcinoma were obtained by traditional sampling method
No interventions assigned to this group
prostate ,landscape sample method
Samples from 100 patients with prostate carcinoma were obtained by landscape sampling method to testify the clinical value and significance of tumor landscape pathological diagnosis .
landscape sample method
200 cases of different tumor tissues will be compared by traditional sample method and landscape sample method to testify the clinical value and significance of tumor landscape pathological diagnosis .
liver, traditional sample method
Samples from 100 patients with liver cancer were obtained by traditional sampling method.
No interventions assigned to this group
liver,landscape sample method
Samples from 100 patients with liver cancer were obtained by landscape sampling method to testify the clinical value and significance of tumor landscape pathological diagnosis .
landscape sample method
200 cases of different tumor tissues will be compared by traditional sample method and landscape sample method to testify the clinical value and significance of tumor landscape pathological diagnosis .
esophageal ,traditional sample method
Samples from 100 patients with esophageal carcinoma were obtained by traditional sampling method.
No interventions assigned to this group
esophageal ,landscape sample method
Samples from 100 patients with esophageal carcinoma were obtained by landscape sampling method to testify the clinical value and significance of tumor landscape pathological diagnosis .
landscape sample method
200 cases of different tumor tissues will be compared by traditional sample method and landscape sample method to testify the clinical value and significance of tumor landscape pathological diagnosis .
GIST,traditional sample method
Samples from 100 patients with gastrointestinal stromal tumor were obtained by traditional sampling method.
No interventions assigned to this group
GIST,landscape sample method
Samples from 100 patients with gastrointestinal stromal tumor were obtained by landscape sampling method to testify the clinical value and significance of tumor landscape pathological diagnosis .
landscape sample method
200 cases of different tumor tissues will be compared by traditional sample method and landscape sample method to testify the clinical value and significance of tumor landscape pathological diagnosis .
colorectal ,traditional sample method
Samples from 100 patients with colorectal carcinoma were obtained by traditional sampling method.
No interventions assigned to this group
colorectal ,landscape sample method
Samples from 100 patients with colorectal carcinoma were obtained by landscape sampling method to testify the clinical value and significance of tumor landscape pathological diagnosis .
landscape sample method
200 cases of different tumor tissues will be compared by traditional sample method and landscape sample method to testify the clinical value and significance of tumor landscape pathological diagnosis .
pancreatic ,traditional sample method
Samples from 100 patients with pancreatic carcinoma were obtained by traditional sampling method.
No interventions assigned to this group
pancreatic,landscape sample method
Samples from 100 patients with pancreatic carcinoma were obtained by landscape sampling method to testify the clinical value and significance of tumor landscape pathological diagnosis .
landscape sample method
200 cases of different tumor tissues will be compared by traditional sample method and landscape sample method to testify the clinical value and significance of tumor landscape pathological diagnosis .
lung cancer,traditional sample method
Samples from 100 patients with lung cancer were obtained by traditional sampling method.
No interventions assigned to this group
lung cancer,landscape sample method
Samples from 100 patients with lung cancer were obtained by landscape sampling method to testify the clinical value and significance of tumor landscape pathological diagnosis .
landscape sample method
200 cases of different tumor tissues will be compared by traditional sample method and landscape sample method to testify the clinical value and significance of tumor landscape pathological diagnosis .
Renal ,traditional sample method
Samples from 100 patients with renal carcinoma were obtained by traditional sampling method.
No interventions assigned to this group
Renal carcinoma,landscape sample method
Samples from 100 patients with renal carcinoma were obtained by landscape sampling method to testify the clinical value and significance of tumor landscape pathological diagnosis .
landscape sample method
200 cases of different tumor tissues will be compared by traditional sample method and landscape sample method to testify the clinical value and significance of tumor landscape pathological diagnosis .
Breast cancer,traditional sample method
Samples from 100 patients with breast cancer were obtained by traditional sampling method.
No interventions assigned to this group
Breast cancer,landscape sample method
Samples from 100 patients with breast cancer were obtained by landscape sampling method to testify the clinical value and significance of tumor landscape pathological diagnosis .
landscape sample method
200 cases of different tumor tissues will be compared by traditional sample method and landscape sample method to testify the clinical value and significance of tumor landscape pathological diagnosis .
cervical ,traditional sample method
Samples from 100 patients with cervical carcinoma were obtained by traditional sampling method.
No interventions assigned to this group
cervical ,landscape sample method
Samples from 100 patients with cervical carcinoma were obtained by landscape sampling method to testify the clinical value and significance of tumor landscape pathological diagnosis .
landscape sample method
200 cases of different tumor tissues will be compared by traditional sample method and landscape sample method to testify the clinical value and significance of tumor landscape pathological diagnosis .
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
landscape sample method
200 cases of different tumor tissues will be compared by traditional sample method and landscape sample method to testify the clinical value and significance of tumor landscape pathological diagnosis .
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Did not receive preoperative preoperative chemotherapy or radiotherapy
Exclusion Criteria
15 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Shanghai Zhongshan Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
B2017-113R
Identifier Type: -
Identifier Source: org_study_id